Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| XWELL, Inc.XWEL · Entity 1233 | Director | August 25, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
XWELL, Inc.
Report date August 25, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 261,122 |
Reported balance
After 2026-08-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-25 · Grant · Acquired 50,000 · Balance 261,122 F1: Represents restricted shares of the Issuer's common stock, par value $0.01 which vested fully on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares of the Issuer's common stock, par value $0.01 which vested fully on the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Sep 3, 2026 01:45 UTC | XWELL, Inc. XWEL · Entity 1233 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-104859 · tm2624717-3_4seq1.xml · nonDerivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,122 F1 · security: Represents restricted shares of the Issuer's common stock, par value $0.01 which vested fully on the date of grant. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 19:43 UTC | XWELL, Inc. XWEL · Entity 1233 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-022416 · tm267701-4_4seq1.xml · nonDerivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,122 F1 · security: Represents 100,000 restricted stock units ("RSUs"), which such RSUs shall vest on the thirtieth (30th) day following the date of grant, provided that the reporting person remains employed by or is providing services to the Issuer. The RSUs were granted subject to the closing of the transaction contemplated by that certain securities purchase agreement, dated as of February 24, 2026, by and between the Company and the purchaser signatory thereto, which occurred on February 27, 2026. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 08:02 UTC | XWELL, Inc. XWEL · Entity 1233 | GrantEmployee stock option (right to buy) · Derivative | 107,724 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001104659-25-055731 · tm2517003-3_4seq1.xml · derivative · entry 2 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,724 Underlying: Common Stock · 107,724 shares Expires 2035-06-02 F2 · security: Represents stock options to purchase up to 107,724 shares of Common Stock with such stock options vesting in four substantially equal installments on the quarterly anniversaries of the grant date, provided that the reporting person is providing services to the Company through such vesting date. F2 · derivative.exercise_date: Represents stock options to purchase up to 107,724 shares of Common Stock with such stock options vesting in four substantially equal installments on the quarterly anniversaries of the grant date, provided that the reporting person is providing services to the Company through such vesting date. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 08:02 UTC | XWELL, Inc. XWEL · Entity 1233 | GrantCommon Stock, par value $0.01 per share | 98,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-055731 · tm2517003-3_4seq1.xml · nonDerivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,122 F1 · price: The reporting person received fully vested restricted stock units, in consideration of the reporting person's Board fees decrease effective in the fourth quarter of 2024. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 18:36 UTC | XWELL, Inc. XWEL · Entity 1233 | GrantEmployee stock option (right to buy) · Derivative | 22,019 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001104659-24-120236 · tm2428798-3_4seq1.xml · derivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,019 Underlying: Common Stock · 22,019 shares Expires 2034-11-15 F1 · security: Represents stock options to purchase up to 22,019 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date. F1 · derivative.exercise_date: Represents stock options to purchase up to 22,019 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:36 UTC Amendment | XWELL, Inc. XWEL · Entity 1233 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001235110-23-000002 · edgar.xml · derivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-01-05 F1 · security: This grant is pursuant to the directors compensation plan. F2 · derivative.exercise_date: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 14:28 UTC | XWELL, Inc. XWEL · Entity 1233 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0000950138-23-000004 · edgar.xml · derivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-01-05 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · derivative.exercise_date: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2023. Read SEC document |
| January 26, 2022 Filed Jan 31, 2022 20:10 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (right to buy) · Derivative | 46,875 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0000950138-22-000030 · edgar.xml · derivative · entry 2 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common Stock · 46,875 shares Expires 2032-01-26 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F3 · derivative.exercise_date: The options vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022. Read SEC document |
| January 26, 2022 Filed Jan 31, 2022 20:10 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-22-000030 · edgar.xml · nonDerivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,485 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · shares: Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 17:27 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000396 · edgar.xml · nonDerivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,235 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · shares: Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of June 30, 2022. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:37 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (right to buy) · Derivative | 43,077 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001235110-21-000004 · edgar.xml · derivative · entry 2 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,077 Underlying: Common Stock · 43,077 shares Expires 2031-01-04 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F3 · derivative.exercise_date: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2021. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:37 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantCommon Stock | 28,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001235110-21-000004 · edgar.xml · nonDerivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,235 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · shares: Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2021. Read SEC document |
| April 20, 2020 Filed Apr 21, 2020 19:57 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001104659-20-049350 · tm2016454d1_4.xml · derivative · entry 1 Lebowitz Michael · CIK 0001808836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-04-20 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F1 · price: These securities were issued as part of the Issuer's equity grant to directors. F2 · derivative.exercise_date: The shares underlying this option vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.